ONCOSCREEN (@oncoscreen) 's Twitter Profile
ONCOSCREEN

@oncoscreen

European "shield" against colorectal cancer based on novel screening methods | Funded by @HorizonEU, grant agreement 101097036 | Views of the project owner only

ID: 1599458184279851010

linkhttps://oncoscreen.health/ calendar_today04-12-2022 17:39:28

277 Tweet

251 Followers

688 Following

ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

🌍 On March 24th, a critical discussion on colorectal cancer (CRC) prevention, as part of the 2025 Cancer Awareness Campaign 'After THAT'. This conference will address the challenges of CRC prevention, early diagnosis, and stigma reduction. For more: ow.ly/Vrhf50VmnZp

ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

🔊Let’s Talk About It: Breaking the Stigma Around Colorectal Cancer This #ColorectalCancerAwarenessMonth, let’s normalise the conversation and encourage screening and prevention. Together, we can make a difference. 👭

ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

🚀 Strategies to Mitigate Financial Barriers in Colorectal Cancer Screening In our latest blog, we explore innovative approaches to reduce financial obstacles and ensure equitable access to early detection and care. Read the full article: ow.ly/eeIR50VpV3V

🚀 Strategies to Mitigate Financial Barriers in Colorectal Cancer Screening

  In our latest blog, we explore innovative approaches to reduce financial obstacles and ensure equitable access to early detection and care.  

 Read the full article: ow.ly/eeIR50VpV3V
ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

🔤 The A-Z of #ONCOSCREEN 🔤​ D is for Data Anonymisation Data anonymisation is a critical process we employ to protect individuals' identities by removing personally identifiable information from datasets. Find out more:oncoscreen.health

ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

💙Fear of a cancer diagnosis is a significant barrier to CRC screening uptake, with only 41% participation last year. Early detection is crucial, as bowel cancer is one of the most treatable forms when caught early. Learn more: ow.ly/6PjA50Vt0Mx

ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

🌍 This #WorldHealthDay, we stand by the right to accessible, fair healthcare for all - starting with access to easier screening. At #OncoScreen, we’re making cancer screening easier, earlier & fairer — because early detection saves lives.💙

🌍 This #WorldHealthDay, we stand by the right to accessible, fair healthcare for all - starting with access to easier screening. 

At #OncoScreen, we’re making cancer screening easier, earlier & fairer — because early detection saves lives.💙
ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

✳️ #ONCOSCREEN Introduction series ✳️ Our next partner is the Hellenic Society of Gastrointestinal Oncology ➡️ Learn more about HSGO: digestiveoncology.org.gr/en/

✳️ #ONCOSCREEN Introduction series ✳️

Our next partner is the Hellenic Society of Gastrointestinal Oncology

➡️ Learn more about HSGO: digestiveoncology.org.gr/en/
ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

Some of our project partners who proudly represented the Oncoscreen Project at the 1st Styrian Run Against Cancer on April 26th, 2025! Organised by the Comprehensive Cancer Center (CCC) Graz at Universitätsklinikum Landeskrankenhaus. Learn more 👉 run-against-cancer.at

Some of our project partners who proudly represented the Oncoscreen Project at the 1st Styrian Run Against Cancer on April 26th, 2025! Organised by the Comprehensive Cancer Center (CCC) Graz at Universitätsklinikum Landeskrankenhaus.

Learn more 👉 run-against-cancer.at
ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

#ONCOSCREEN's next Plenary Meeting is coming up! Our partners are preparing to travel to Kaunas, Lithuania on May19-22 for the second Plenary of the project. This will be a great opportunity to share progress updates and lay the groundwork for the next phase.

ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

Day 2 of the #ONCOSCREEN Plenary is off to a strong start in Kaunas! 🌤️ This morning, we’re diving into: 🔹 Dissemination, communication & impact strategies with Carr Communications 🔹 Clinical trial design & validation insights lead by FIRALIS S.A. Stay tuned for more!

ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

This afternoon at the #ONCOSCREEN Plenary 🛡️ Risk mitigation strategies for clinical trials with UMC Mainz & FIRALIS S.A. 🔧 System architecture finalisation with ICCS 💼 IPR & exploitation planning with EXUS AI LABS 🗣️ Citizen awareness workshop led by Europacolon

This afternoon at the #ONCOSCREEN Plenary

🛡️ Risk mitigation strategies for clinical trials with UMC Mainz &amp; <a href="/FiralisGroup/">FIRALIS S.A.</a> 

🔧 System architecture finalisation with ICCS 

💼 IPR &amp; exploitation planning with <a href="/exus_AILabs/">EXUS AI LABS</a>   

🗣️ Citizen awareness workshop led by Europacolon
ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

🎯 Day 3 of the #ONCOSCREEN Plenary kicks off with our Oncological Living Lab on CRC Tools! Patients, clinicians & policymakers are testing ONCOSCREEN innovations hands-on—from #AI-powered diagnostics to privacy-preserving platforms. Real users. Real feedback. Real impact. 🔍💬

ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

🔬 Wrapping up Day 3 of the #ONCOSCREEN Plenary with tool demos & real-world testing! 🛠️ From ONCOCRISPR to ONCOVOC, partners showcased diagnostic tools & AI platforms ✅ Evaluation led by ICCS & POLA ensured tools meet user needs Collaboration in action! 🚀

ONCOSCREEN (@oncoscreen) 's Twitter Profile Photo

Day 4 of the #ONCOSCREEN Plenary is all about the ONCOLOGICAL Living Labs! 🤝 Our partners have gathered for an interactive session led by industry experts 🔹 Focus on CRC policy, financing & citizen engagement 🔹 Next steps: ONCOTHON & future Living Labs planning!